ASSOCIATED PRESS — WASHINGTON (AP) — An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot. The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.
Posted
and last updated
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
,
Weather
Tuesday
02/04/2025
Rain
-° / 48°
74%
Wednesday
02/05/2025
Mostly Clear
55° / 41°
8%
Thursday
02/06/2025
Showers Late
69° / 54°
36%
Friday
02/07/2025
Partly Cloudy
61° / 41°
10%
Saturday
02/08/2025
Partly Cloudy
58° / 40°
5%
Sunday
02/09/2025
Clear
58° / 37°
7%
Monday
02/10/2025
Partly Cloudy
58° / 37°
8%
Tuesday
02/11/2025
Partly Cloudy
59° / 38°
18%